A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug targetSrivastava, Prashant K.; Eyll, Jonathan van; Godard, Patrice; Mazzuferi, Manuela; Delahaye-Duriez, Andree; Steenwinckel, Juliette Van; Gressens, Pierre; Danis, Benedicte; Vandenplas, Catherine; Foerch, Patrik; Leclercq, Karine; Mairet-Coello, Georges; Cardenas, Alvaro; Vanclef, Frederic; Laaniste, Liisi; Niespodziany, Isabelle; Keaney, James; Gasser, Julien; Gillet, Gaelle; Shkura, Kirill; Chong, Seon-Ah; Behmoaras, Jacques; Kadiu, Irena; Petretto, Enrico; Kaminski, Rafal M.; Johnson, Michael R. · Nature Communications · 2018

Leishmaniasis: a reviewTorres-Guerrero, Edoardo; Quintanilla-Cedillo, Marco Romano; Ruiz-Esmenjaud, Julieta; Arenas, Roberto · F1000Research · 2017

Updates in diabetic peripheral neuropathyJuster-Switlyk, Kelsey; Smith, A. Gordon · F1000Research · 2016

Progressive Multifocal LeukoencephalopathyAdang, Laura; Berger, Joseph · F1000Research · 2015

Early detection of lung cancerMidthun, David E. · F1000Research · 2016

SevofluraneDe Hert, Stefan; Moerman, Anneliese · F1000Research · 2015

Plant adaptation to drought stressBasu, Supratim; Ramegowda, Venkategowda; Kumar, Anuj; Pereira, Andy · F1000Research · 2016

Recent advances in understanding vitiligoManga, Prashiela; Elbuluk, Nada; Orlow, Seth J. · F1000Research · 2016

Recent Understandings of Pet AllergiesOwnby, Dennis; Johnson, Christine Cole · F1000Research · 2016